• 1. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
• 2. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 3. Evidence of field induced slow magnetic relaxation in cis-[Co(hfac)2(H2O)2] exhibiting tri-axial anisotropy with a negative axial component?
  Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548
• 4. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 5. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Thiazolecarboxylic acids and derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Thiazoles Thiazolecarboxylic acids and derivatives

Research Brief on 2,4-Dibromo-5-thiazolecarboxylic acid (CAS: 139669-96-8): Recent Advances and Applications

2,4-Dibromo-5-thiazolecarboxylic acid (CAS: 139669-96-8) is a brominated thiazole derivative that has garnered significant attention in the field of chemical biology and pharmaceutical research. This compound serves as a versatile intermediate in the synthesis of various bioactive molecules, particularly in the development of antimicrobial, antiviral, and anticancer agents. Recent studies have highlighted its potential in drug discovery, owing to its unique chemical properties and reactivity. This research brief aims to provide an overview of the latest advancements related to this compound, focusing on its synthesis, applications, and mechanistic insights.

In a recent study published in the Journal of Medicinal Chemistry, researchers explored the role of 2,4-Dibromo-5-thiazolecarboxylic acid as a key building block in the synthesis of novel thiazole-based inhibitors targeting bacterial DNA gyrase. The study demonstrated that derivatives of this compound exhibited potent inhibitory activity against Gram-positive pathogens, including methicillin-resistant Staphylococcus aureus (MRSA). The findings underscore the potential of this scaffold in addressing the growing challenge of antibiotic resistance.

Another significant application of 2,4-Dibromo-5-thiazolecarboxylic acid was reported in the context of antiviral drug development. A 2023 study in Bioorganic & Medicinal Chemistry Letters detailed its use in the design of small-molecule inhibitors targeting the RNA-dependent RNA polymerase (RdRp) of SARS-CoV-2. The researchers utilized the bromine substituents of the compound to facilitate selective binding to the viral enzyme, resulting in improved inhibitory potency. This work highlights the adaptability of 2,4-Dibromo-5-thiazolecarboxylic acid in addressing emerging viral threats.

From a synthetic chemistry perspective, advancements have been made in optimizing the production of 2,4-Dibromo-5-thiazolecarboxylic acid. A recent patent (WO2023056321) disclosed a novel catalytic method for its synthesis, achieving higher yields and reduced environmental impact compared to traditional bromination techniques. This innovation is expected to enhance the scalability of this compound for industrial applications.

In conclusion, 2,4-Dibromo-5-thiazolecarboxylic acid (CAS: 139669-96-8) continues to be a valuable asset in chemical biology and pharmaceutical research. Its diverse applications, ranging from antimicrobial agents to antiviral therapeutics, demonstrate its broad utility. Future research directions may focus on further elucidating its structure-activity relationships and exploring its potential in other therapeutic areas, such as neurodegenerative diseases or metabolic disorders.

• 1784018-31-0(4-bromo-2-methyl-1,3-thiazole-5-carboxylic acid)
• 1353100-73-8(Methyl 4-bromothiazole-5-carboxylate)
• 918164-43-9(methyl 2,4-dibromothiazole-5-carboxylate)
• 54045-76-0(2-bromo-1,3-thiazole-5-carboxylic acid)
• 170232-68-5((2,4-dibromothiazol-5-yl)methanol)
• 139669-95-7(2,4-Dibromothiazole-5-carboxaldehyde)
• 848500-45-8(Ethyl 2,4-dibromothiazole-5-carboxylate)
• 1244949-48-1(4-Bromothiazole-5-carboxylic acid)
• 152300-60-2(4-Bromo-5-thiazolecarboxylic acid ethyl ester)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)